Oncology Data Advisor

i3 Health
  • 4.4 (12)
  • SCIENCE
Oncology Data Advisor

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

  1. What’s New With HER2: Charting New Paths in NSCLC Care Module 1 Podcast: HER2 in NSCLC: Actionable Insights and Testing Recommendations

    12/20/2024

    What’s New With HER2: Charting New Paths in NSCLC Care Module 1 Podcast: HER2 in NSCLC: Actionable Insights and Testing Recommendations

    Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions. In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now! Click here to claim CME/NCPD credit: https://bit.ly/49NCaQu

    15 min
  2. What’s New With HER2: Charting New Paths in NSCLC Care Module 2 Podcast

    12/20/2024

    What’s New With HER2: Charting New Paths in NSCLC Care Module 2 Podcast

    Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies. In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now! Click here to claim CME/NCPD credit: https://bit.ly/405xEJO

    19 min
  3. Ontada, Microsoft, and Azure AI: Collaborating to Transform Real-Word Data Processing in Oncology

    12/12/2024

    Ontada, Microsoft, and Azure AI: Collaborating to Transform Real-Word Data Processing in Oncology

    In this episode of Exploring Artificial Intelligence in Oncology, Wanmei Ou, PhD, the Vice President of Product, Clinical Decision Support, & Analytics Data Platform at Ontada, shares more about Ontada’s collaboration with Microsoft to transform unstructured oncology data with Azure OpenAI technology. Her discussion with Dr. Waqas Haque highlights how AI is transforming clinical workflows, reducing documentation burdens, and driving improved patient outcomes.

    19 min
  4. Zanidatamab: A New Frontier in Treating HER2-Positive Biliary Tract Cancer With James Harding, MD

    12/11/2024

    Zanidatamab: A New Frontier in Treating HER2-Positive Biliary Tract Cancer With James Harding, MD

    The FDA's recent accelerated approval of zanidatamab marks a significant breakthrough in the treatment landscape for human epidermal growth factor receptor 2 (HER2)–positive biliary tract cancer (BTC). Following the approval, Dr. James Harding, Associate Attending Physician in the Gastrointestinal Oncology and Early Drug Development Services at Memorial Sloan Kettering Cancer Center, sat down to provide oncology clinicians with insights into its significance and implications for clinical practice.

    17 min
  5. Lung Cancer Awareness Month: Treatment Updates in 2024

    11/26/2024

    Lung Cancer Awareness Month: Treatment Updates in 2024

    As Lung Cancer Awareness Month progresses, this discussion hosted by Oncology Data Advisor sheds light on the advancements in lung cancer therapies, unmet needs, the evolving landscape of molecular testing, and actionable insights for clinicians.

    15 min
  6. Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast

    11/22/2024

    Diagnosis and Management of Dedifferentiated Liposarcoma: A Multidisciplinary Task Force Podcast

    Gain valuable insights into the complexities of diagnosing and managing dedifferentiated liposarcoma (DDLPS) and earn free CME credit with our latest podcast. This episode features expert guidance from Dr. Richard F. Riedel of Duke University and Dr. Candace L. Haddox of Dana-Farber Cancer Institute. Delve into the latest on identifying MDM2 and CDK4 amplification, challenges in diagnosing DDLPS, and updates on emerging therapies like CDK4/6 inhibitors and immunotherapies. Learn how a multidisciplinary approach enhances patient outcomes in this rare and aggressive soft tissue sarcoma. Listen now and advance your expertise! Click here to claim your CME credit: i3health.com/course-information/podcast-ddlps

    29 min
  7. Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma

    11/12/2024

    Clinic Conversation of the Week: How to Talk to Patients About the BENEFIT Trial in Multiple Myeloma

    The BENEFIT trial, which studied isatuximab, lenalidomide, dexamethasone, and bortezomib in transplant-ineligible multiple myeloma, was published earlier this year in Nature Medicine. I'll be talking about this as if it was one of my patients coming to me with a copy of this paper in their hand that a friend or loved one forwarded to them. What do I tell them?

    6 min
  8. Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO

    11/07/2024

    Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO

    Artera: Personalizing Treatment Decisions in Prostate Cancer and Beyond With Waqas Haque, MD, MPH, and Trevor Royce, MD, MS, MPH, FASCO by i3 Health

    15 min
See All (402)

Ratings & Reviews

4.4
out of 5
12 Ratings

About

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Information

  • Creator
    i3 Health
  • Years Active
    2014 - 2024
  • Episodes
    402
  • Rating
    Clean
  • Copyright
    © All rights reserved
  • Show Website
    Oncology Data Advisor

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada